Objective Preterm birth (PTB) is associated with excess maternal cardiovascular disease risk. We considered that women with PTB and placental evidence of maternal malperfusion would be particularly affected.
Introduction
Cardiovascular disease (CVD) is the leading cause of death among women in the USA. Stagnant rates of CVD mortality in younger women have occurred alongside notable declines in men and older adults, 1 suggesting that early identification of risk in women is essential. The American Heart Association most current guidelines indicate that a history of preterm birth may identify women in whom cardiovascular risk factor screening and management is warranted, 2 although mechanisms linking these conditions are not understood. 3 PTB research has traditionally focused on clinical presentation to classify subtypes. For example, spontaneous preterm labour, preterm membrane rupture or medically induced preterm deliveries are thought to have distinct pathophysiologies. This approach has limitations, as the epidemiologic outcomes, metabolic changes and abnormalities of implantation in indicated and spontaneous PTB overlap. We have reported that using placental features to classify PTB subtypes can predict newborn health, 4 and now consider that placental phenotypes may also portend maternal cardiovascular health in the decade after delivery.
Placental malperfusion has well-established associations with pre-eclampsia and growth restriction but also with spontaneous PTB. [5] [6] [7] Indeed, 'defective deep placentation' is associated with a subset of each of the 'great obstetrical syndromes,' including PTB. 8 The main pathologic features of placental malperfusion are decidual vasculopathy, villous infarcts, abruption, and accelerated villous maturation. 9 Vasculopathy is the underlying cause of many other placental changes including infarcts and abruption, and the prominent features are incomplete of spiral artery conversion and early atherosclerosis-like findings such as atherosis. Another common feature is accelerated villous maturation, detected as villi substantially smaller than expected for the gestational age, increased aggregates of nuclei in the syncytiotrophoblast known as syncytial knots, or aberrantly narrow, elongated villi termed distal villous hypoplasia. Syncytial knots are present in modest numbers in uncomplicated pregnancies, increasing steadily throughout gestation, but excess syncytial knots may reflect chronic hypoxia-reperfusion injury. 10 We considered that placental malperfusion may reflect the accumulation of maternal factors, such as hyperlipidaemia and inflammation, which impair the vascular adaptations required to support a fullterm, healthy pregnancy. As such, placental malperfusion may also provide a window into future maternal cardiometabolic risk.
We hypothesised that compared with women with term, uncomplicated births, women with preterm births and placental malperfusion would have higher blood pressure, a more atherogenic biomarker profile and higher carotid intima media thickness, a marker of subclinical atherosclerosis that predicts cardiovascular events. We further considered that signs of placental malperfusion plus additional placental lesions involving infection or inflammation may mark women with particularly high cardiometabolic risk after delivery.
Materials and methods
The Women and Infant Study of Healthy Hearts (WISH) is a cohort study of cardiovascular factors assessed 4-12 years after delivery of singleton small-for-gestation-age (SGA), preterm infants or term births. The University of Pittsburgh IRB approved all study procedures. Eligibility and recruitment results have been reported previously. 11 Briefly, eligible women were randomly selected from those who gave birth between 1997 and 2002 at Magee-Women' Hospital in Pittsburgh, PA, who did not have pre-eclampsia, pre-pregnancy hypertension or pre-existing diabetes. By design, women with these conditions were not enrolled in this study. A total of 702 women provided informed consent and were enrolled. Those with term SGA infants were excluded, as the pathways involved in SGA and PTB may be distinct and the post pregnancy consequences may also be different. Six women with PTB also had SGA infants, but replication of the analysis after removing these cases did not change the results, so they are included. We excluded women who reported their race/ ethnicity as other than white or African American, (n = 12), those with gestational diabetes (n = 11) and women with triglycerides >400 mg/dl (n = 2), as the estimation of LDL-cholesterol (LDL-C) is not valid in these individuals. 12 We further restricted PTB cases (<37 weeks) to those with clinical placental pathology records (115/ 181). PTBs without pathology records were more likely to be late PTBs [mean gestational age 35.4 (SD 1.0) versus 33.1 (2.7), P < 0.0001). In the current study the comparison group comprised 242 women with term, uncomplicated births and no conditions warranting referral of a placenta for pathology review (79% of women with term births). Among this group, those with any self-reported preterm births were also excluded (n = 32). Although no placental features were available in this group, our institutional criteria for referral to pathology were broad during this period, with 45.4% of births sent for evaluation. 13 Thus, placentas not referred to pathology likely represent healthy pregnancies. There were no differences in cardiovascular risk factors measured after pregnancy among women with and without placental pathology, providing assurance that bias in the availability of placental data may be small (Supporting Information Table S2 ).
Gestational age at delivery was based on the date of the last menstrual period (LMP) and ultrasound when available. At our hospital during this time period, 60% of deliveries had early (18-22 weeks) dating ultrasound. When the two dates (LMP and ultrasound) differed by less than 2 weeks, gestational age was based on LMP; when they differed by more than 2 weeks, dating was based on ultrasound. Pre-pregnancy body mass index (BMI; self-reported at the first prenatal visit) and smoking status were abstracted from the medical record. For 37 women with missing pre-pregnancy BMI (n = 2 term births; n = 35 preterm births) we used multiple imputation to estimate prepregnancy BMI based on weight at first prenatal visit, delivery weight, age, race, height, smoking, and cardiometabolic factors measured at the WISH follow-up visit (BMI, systolic and diastolic blood pressure, total cholesterol, HDL-C and triglycerides). [14] [15] [16] By design, women with pre-eclampsia and term SGA infants (birthweight <10 th percentile) were excluded, and the medically indicated preterm births in our study were related to placenta praevia, abruption and other fetal or maternal conditions. Cases of gestational hypertension (blood pressure above 140/90 mmHg without proteinuria, n = 5) were included, as results were unchanged after their exclusion.
Presence of placental lesions was abstracted from the clinical pathology reports of women with PTB and categorised according to proposed schemas as placental malperfusion (vasculopathy, infarct, accelerated villous maturation, perivillous fibrin deposition, intervillous fibrin deposition), intra-uterine infection/inflammation (III, acute chorioamnionitis, acute funisitis, acute vasculitis, acute deciduitis), villitis of unknown aetiology (a marker of chronic inflammation), fetal thrombosis or chorangiosis. 13, 17, 18 A detailed description of placental lesion definitions is provided in Supporting Information Table S1 . [19] [20] [21] [22] During this period, placental pathologists prepared all reports following a standardised protocol using a uniform reporting approach and identical diagnostic criteria. As these placentas were examined for clinical indications, a limited amount of clinical history was available to the pathologist. Data abstraction was overseen by two pathologists (W.T.P. and L.N.N.).
To investigate the utility of the clinical pathology reports, a small validation study was performed (n = 56 spontaneous PTBs, 19 medically indicated PTBs, and 50 term births). The diagnosis of malperfusion and infection/ inflammation on the clinical pathology reports was compared with a review of the slides by a single pathologist (W.T.P.) blinded to all clinical information except gestational age. There was excellent agreement among PTBs (82% overall agreement, kappa = 0.74) for infection/inflammation, and fair agreement (62% overall agreement, kappa = 0.22) for malperfusion lesions. Of note, the clinical report tended to under-report cases of malperfusion in both spontaneous (34 versus 54%, respectively) and indicated PTBs (47 versus 79%). Overall agreement was excellent for the malperfusion lesions among term births (82%) but kappa was fair (0.26), likely due to the relatively rare occurrence of this feature (the clinical pathology records indicated 4% of term, uncomplicated births had evidence of malperfusion).
At a research visit occurring 4-12 years after delivery (WISH follow-up visit), B-mode ultrasound images of the right and left distal common carotid artery, carotid bulb, and the first centimetre of the internal carotid artery were obtained in diastole. Using semi-automated edge-detection software (ARTERY MEASUREMENT SYSTEM, Gothenburg, Sweden), the lumen-intima and media-adventitia interfaces were identified and measured across 1-cm segments of the near and far walls of the common carotid artery and the far wall of the bulb and internal carotid artery. Reproducibility of IMT measures was excellent, with an intraclass correlation coefficient between sonographers of ≥0.87 and between readers of 0.92.
Fasting blood samples were collected at the same study visit. Total cholesterol, HDL-C, and triglycerides were measured using standard enzymatic procedures and the coefficient of variation (CV) ranged from 1.3 to 6.5%. LDL-C was evaluated using the Friedewald calculation. 12 Apolipoprotein B (ApoB) was analysed using a variation of the Boehringer Mannheim turbidimetric procedure and the CV was 9.8%. High sensitivity C-reactive protein (hsCRP) was measured using reagents obtained from Carolina Liquid Chemicals (Brea, CA, USA) with a CV of 5.5%. Interleukin (IL)-6 (pg/ml) was measured using the Quantikine HS ELISA kit from R&D Systems, Inc. (Minneapolis, MN, USA). The intra-and interassay variabilities were 7.4 and 7.8%, respectively.
Blood pressure was evaluated following a research protocol using appropriately sized cuffs based on arm measurements and a manual sphygmomanometer. Body mass index (BMI, kg/m²) was calculated from measured height and weight. Waist circumference was assessed with a tape measure at the umbilicus. Women completed a structured interview to assess reproductive and medical history, demographics, and lifestyle characteristics. Women reported the outcomes of all pregnancies before and following the index birth including gestational age and birth weight. Women also reported the first day of the last menstrual period, and days from menses to the study visit for pre-menopausal women were calculated because some markers may change during the menstrual cycle. 23, 24 Menopause was defined as having no menstrual periods during the previous 12 months, surgical removal of both ovaries or age greater than 55 accompanied by use of estrogen, hormone therapy or a hysterectomy. Physical activity was reported using the Paffenbarger Physical Activity Questionnaire 25 and analysed as total hours of physical activity expenditure per week (MET hours/week).
Characteristics of women with PTB according to presence or absence of placental malperfusion lesions were compared with those of women with term births using Chi-square tests for categorical variables and ANOVA for continuous variables. The Wilcoxon rank sum test was used instead of the t-test if the normality assumption did not hold, based on quantile-quantile plots, histograms, and the Shapiro-Wilk test for normality. Blood pressure and biomarkers were evaluated as continuous outcomes according to presence of placental malperfusion. We then evaluated women with malperfusion plus other lesions, malperfusion only, and no malperfusion lesions, compared with women with term births. Group differences were compared using linear regression, adjusted for pre-pregnancy features (age, race, pre-pregnancy BMI, smoking in pregnancy) and the years between pregnancy and cardiovascular measurement. Differences in carotid IMT were first adjusted for these pre-pregnancy features and then subsequently adjusted for cardiovascular risk factors (blood pressure, atherogenic lipids, current smoking) that may be intermediates linking pregnancy to subclinical atherosclerosis. Lipid components were, as expected, highly correlated and therefore we tested models adjusted for each (rather than all) and present results for apolipoprotein B, as that is most atherogenic lipid component measured. Estimates that separately accounted for triglycerides and total cholesterol were similar. Results were replicated after removing post-menopausal women, those with gestational hypertension and those who delivered post-term (at or after 41 completed weeks'). All tests were two-sided with statistical significance set at P-value <0.05. We did not adjust for multiple comparisons given the modest sample studied, and results should be interpreted with caution. Analyses were performed with SAS (version 9.4, SAS Institute, Inc., Cary, NC, USA) and R (version 3.3, R Foundation for Statistical Computing, Vienna, Austria).
Results
In 115 women with PTB, 48 (42%) had evidence of placental malperfusion and 67 (58%) did not. Women with malperfusion lesions tended to be modestly older than women with term births, and those with PTBs with or without malperfusion had lower household income and higher rates of smoking after pregnancy compared with women with term births (Supporting Information  Table S3 ). Inflammation/infection affected 25.2% of PTBs (n = 30) and these were similarly distributed among cases with or without malperfusion. Villitis of unknown aetiology was relatively rare, but all cases co-occurred with malperfusion lesions. The majority of PTBs were spontaneous regardless of evidence of malperfusion.
Women with PTB and accelerated villous maturation or infection/inflammation delivered the earliest and smallest infants (Table 1) . Those with malperfusion lesions (accelerated villous maturation, infarcts or perivillous fibrin) in general had higher blood pressure, lipids and thicker carotid IMTs 4-12 years after delivery compared with women with term births. Women with PTB and villitis had particularly high triglycerides and thicker IMTs, and women with infection/inflammation or perivillous fibrin had higher IL-6 concentrations in the years after pregnancy. The more atherogenic profile of women with PTB and placental evidence of malperfusion (higher SBP and total cholesterol) persisted after adjustment for age, race, pre-pregnancy BMI, smoking and years from delivery to the cardiovascular screening visit (Table 2) .
Atherogenic lipid fractions were higher in the group with malperfusion plus other lesions, compared with control women, after accounting for pre-pregnancy factors (n = 21; Figure 1 ). In particular, significant differences were noted for total cholesterol and apolipoprotien-B. In contrast, blood pressure was elevated in the group with malperfusion PTBs and no other lesions present, and LDL-c was higher in the PTB group without malperfusion lesions.
The group with malperfusion plus other lesions had thicker IMTs compared with women with term births (difference 0.060, P = 0.002; Table 3 ) and this difference remained robust in models adjusted for pre-pregnancy covariates (difference +0.038, P = 0.025). This was attenuated to no longer significant after accounting for traditional cardiovascular risk factors that likely emerged after delivery and may link pregnancy to later subclinical atherosclerosis (higher blood pressure and apolipoprotein B; difference +0.027, P = 0.095). The malperfusion-only group and those without malperfusion lesions did not have higher IMTs. Results were unchanged after removing post-menopausal women (n = 32), women with gestational hypertension (n = 5) and women who delivered after 41 completed weeks (n = 3). Although numbers were small, race-specific analysis suggested that the carotid IMT differences in women with PTB and placental malperfusion plus other lesions were detectable in both white and black women (Supporting Information Table S4 ).
Discussion

Main findings
Our results suggest that classifying PTBs according to placental pathology may reveal subgroups of women with a higher cardiovascular risk factor burden in the decade after pregnancy. We have previously reported that women with a prior PTB have a more atherogenic profile after pregnancy compared with those with term births, but results were modest and comparisons imprecise. 26 In contrast, characterising PTBs according to placental findings identified groups with a particularly elevated atherogenic Groups are compared with women with term births, adjusted for race, age at delivery, pre-pregnancy BMI, smoking during pregnancy, and years between pregnancy and cardiovascular screening visit. Figure 1 . Mean differences in maternal lipids and blood pressure measured 4-12 years after delivery, according to prior preterm birth with placental malperfusion and other lesions: malperfusion and other lesions, black bars (n = 21); malperfusion only, medium grey bars (n = 27); no malperfusion, light grey bars (n = 67). Women with term births are the referent, and estimates are adjusted for age at delivery, race, pre-pregnancy BMI, smoking, and interval between delivery and cardiovascular screening visit. Differences noted with (*) are statistically significant (P < 0.05) compared with women with term births. Other lesions include infection/inflammation (n = 30), villitis (n = 6), fetal thrombosis (n = 20) and chorangiosis (n = 9). Women with PTBs or no lesions (n = 2) were excluded.
profile. The women in our sample with PTB and placental malperfusion plus other lesion types (18% of PTBs evaluated) had higher atherogenic lipids and thicker carotid IMTs after delivery that were independent of pre-pregnancy covariates.
Our results are consistent with the possibility that placental malperfusion may be the consequential, unifying feature that links adverse pregnancy outcomes such as PTB to long-term maternal cardiovascular risk. Malperfusion alone, however, may not be sufficient to mark those at highest risk. Atherosclerotic vascular disease is a chronic inflammatory, fibroproliferative disease of large and medium-sized arteries fuelled by lipids, 27 and placental malperfusion combined with other pathologies may reflect a similar process. We and others have demonstrated that women who subsequently deliver preterm have higher atherogenic lipids and excess inflammation during pregnancy compared with those who deliver at term. [28] [29] [30] [31] [32] We have recently reported that PTBs with co-occurrence of malperfusion and infection/inflammation were associated with smaller infant size, earlier delivery and excess neonatal intraventricular haemorrhage. 4 Our current results suggest that placentas with evidence of multiple pathological processes may also mark women susceptible to a higher cardiometabolic burden detectable within the decade after pregnancy. Our results were robust after removing the five women with gestational hypertension and therefore women with malperfusion preterm births were normotensive during pregnancy and have higher blood pressure in the decade after delivery. These data support the possibility that measures of traditional cardiovascular risk factors during pregnancy may not fully capture risk that can be detected in the placenta.
Strength and limitations
Consideration of study limitations is warranted. We could not observe overt CVD events among these relatively young, healthy women, although higher carotid IMT is an early stage of arterial injury and atherosclerosis that is predictive of later CVD events. [33] [34] [35] By design, women with pre-eclampsia were not enrolled in our study and future studies should include this group, as they may likely be the most severely affected. We also had a larger portion of early preterm births, due to the requirement to have placental evaluations. Thus, our results are likely generalisable to Black and White women with early preterm births. We were unable to evaluate the maternal sequelae related to specific lesion types due to small numbers. Certain lesions, however, may be linked to a particularly adverse maternal profile (as was suggested in our data) and larger studies should examine this possibility. The placental pathology results utilised were derived from standard clinical reviews and these may have varying reproducibility. Indeed, although overall agreement between blinded research review and clinical reports for malperfusion lesions was moderate, agreement was fair according to the kappa statistic, which accounts for the agreement expected by chance. Although there are limitations regarding the kappa statistic, 36 current efforts to standardise placenta pathology criteria designed to improve inter-rater reliability will help to improve this in the future. 37 In addition, the most severe lesions, such as vasculopathy, villitis and acute chorioamnionitis are highly reproducible. [38] [39] [40] We were unable to explore how pregnancy blood pressure features, even within the normotensive range, might impact occurrence of malperfusion lesions and later life sequelae. In addition, we were unable to examine the pathology that may be present in uncomplicated term births and thus our results may be an underestimate of the true associations. Prior evidence suggests that malperfusion affects as few as 4% of term uncomplicated births, 5 and our validation study reported this same percentage of affected term placentas. We also were unable to evaluate the profile of women before pregnancy, and in the years between delivery and our one-time exam. We were unable to examine preterm birth recurrence, as numbers were small and placental features for other births were not available. Strengths of our study include a robust set of cardiometabolic endpoints, the use of placental pathology to classify PTBs, and the large number of Black women (26%), as PTB disproportionately affects Black women in the USA.
Interpretation
There are very few studies of PTB subtypes and maternal cardiometabolic risk factors after delivery and none, to our knowledge, have related placental findings to later maternal health. The Avon Longitudinal Study of Parents and Children reported that women with PTB have higher blood pressure 18 years after delivery that was largely explained by hypertension during pregnancy. 41 Perng et al. have reported similar results in a US cohort. 42 We have previously demonstrated that women with PTBs have higher blood pressure across 20 years of follow up due to hypertension in pregnancy in the years proximal to pregnancy, but after 10 years of follow up, blood pressure increased more rapidly in women with a prior normotensive preterm compared with term birth. 43 In our previous report of the current cohort, women with early (<34 weeks) or medically indicated PTB had a more atherogenic lipid profile measured in the decade after delivery. 26 Our current results raise the possibility that classifying PTB by placental characteristics may help identify underlying aetiologies that cross clinical presentation subtypes.
Adequate placentation requires invasion of the fetal trophoblast into the maternal decidua, a process that is modulated by maternal factors. 44 Malperfusion, therefore, may reflect both maternal and fetal abnormalities, and future molecular work that can distinguish each component may provide further mechanistic insights.
Conclusion
Our findings suggest that women with PTBs with placental malperfusion, without pre-eclampsia or growth restriction, have higher blood pressure, higher atherogenic lipids and more subclinical atherosclerosis compared with women with uncomplicated term pregnancies. Those with comorbid placental pathologies, in particular those with malperfusion and acute or chronic inflammation, had the most atherogenic profile in the decade after pregnancy. The placenta may offer unique insight into how PTB can portend maternal cardiovascular disease.
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